Paladin Pharma Overview

  • Year Founded
  • 1983

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 403

Employees

  • Latest Deal Type
  • M&A
  • (Announced)

  • Financing Rounds
  • 5

  • Investments
  • 17

Paladin Pharma General Information

Description

Operator of a specialty pharmaceutical company intended for the Canadian and other international markets. The company is focused on developing, acquiring, in-licensing, and commercializing pharmaceutical products, delivering medicines to patients through development, manufacturing and commercialization.

Contact Information

Formerly Known As
Geriatrx Pharmaceutical Corp., Canguard Pharma
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 100 Boulevard Alexis-Nihon
  • Suite 600
  • Saint-Laurent, Quebec H4M 2P2
  • Canada
Primary Industry
Pharmaceuticals
Parent Company
Corporate Office
  • 100 Boulevard Alexis-Nihon
  • Suite 600
  • Saint-Laurent, Quebec H4M 2P2
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Paladin Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Paladin Pharma‘s full profile, request access.

Request a free trial

Paladin Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a specialty pharmaceutical company intended for the Canadian and other international markets. The company is
Pharmaceuticals
Saint-Laurent, Canada
403 As of 2012

Montreal, Canada
 

Mississauga, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Paladin Pharma Competitors (2)

One of Paladin Pharma’s 2 competitors is Knight Therapeutics, a Corporation company based in Montreal, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Knight Therapeutics Corporation Montreal, Canada
Acerus Pharmaceuticals Corporation Mississauga, Canada
You’re viewing 2 of 2 competitors. Get the full list »

Paladin Pharma Patents

Paladin Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2797098-A1 Non-intravenous dosage form comprising solid formulation of liquid biologically active agent and uses thereof Active 23-Apr-2010
EP-2563349-A1 Non-intravenous dosage form comprising solid formulation of liquid biologically active agent and uses thereof Inactive 23-Apr-2010
JP-2017186346-A Non-intravenous dosage form comprising solid formulation of liquid biologically active component and uses thereof Active 23-Apr-2010
EP-2563349-A4 Non-intravenous dosage form comprising solid formulation of liquid biologically active agent and uses thereof Inactive 23-Apr-2010
CA-2797098-C Non-intravenous dosage form comprising solid formulation of liquid biologically active agent and uses thereof Active 23-Apr-2010 A61K31/05
To view Paladin Pharma’s complete patent history, request access »

Paladin Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Paladin Pharma Investments & Acquisitions (17)

Paladin Pharma’s most recent deal was a Seed Round with Change Donations for . The deal was made on 01-Feb-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Change Donations 01-Feb-2020 Seed Round Financial Software
Litha Healthcare Group 15-Oct-2014 Secondary Transaction - Private Distributors (Healthcare)
Triton Pharma 13-Jan-2014 Merger/Acquisition Pharmaceuticals
Litha Healthcare Group 30-Sep-2013 Merger/Acquisition Distributors (Healthcare)
Allon Therapeutics 16-Jul-2013 Merger/Acquisition Biotechnology
You’re viewing 5 of 17 investments and acquisitions. Get the full list »

Paladin Pharma Exits (6)

Paladin Pharma’s most recent exit was on 15-Oct-2014 from Litha Healthcare Group. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Litha Healthcare Group 15-Oct-2014 Completed
Litha Healthcare Group 30-Sep-2013 Completed
Telesta Therapeutics 06-Jun-2013 Completed
Litha Healthcare Group 21-Feb-2012 Completed
Afexa Life Sciences 15-Jul-2011 Secondary Transaction - Open Market Completed
You’re viewing 5 of 6 exits. Get the full list »

Paladin Pharma FAQs

  • When was Paladin Pharma founded?

    Paladin Pharma was founded in 1983.

  • Where is Paladin Pharma headquartered?

    Paladin Pharma is headquartered in Saint-Laurent, Canada.

  • What is the size of Paladin Pharma?

    Paladin Pharma has 403 total employees.

  • What industry is Paladin Pharma in?

    Paladin Pharma’s primary industry is Pharmaceuticals.

  • Is Paladin Pharma a private or public company?

    Paladin Pharma is a Private company.

  • What is the current valuation of Paladin Pharma?

    The current valuation of Paladin Pharma is .

  • What is Paladin Pharma’s current revenue?

    The current revenue for Paladin Pharma is .

  • How much funding has Paladin Pharma raised over time?

    Paladin Pharma has raised $13.9M.

  • Who are Paladin Pharma’s competitors?

    Knight Therapeutics and Acerus Pharmaceuticals are competitors of Paladin Pharma.

  • When was Paladin Pharma acquired?

    Paladin Pharma was acquired on 11-Mar-2025.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »